← Open Payments lookup

ROBERT NELSON: Open Payments

NPI 1972696037 · WYOMISSING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$391,783 in 471 payments from 16 companies in 2025. Trend: 2023 $358,011 · 2024 $408,743 · 2025 $391,783

Speaker / faculty: $272,561Honoraria: $60,125Travel & lodging: $36,875Consulting: $11,490Food & beverage: $10,733
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.116$103,930
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)124$103,609
Otsuka America Pharmaceutical, Inc.90$73,899
Axsome Therapeutics, Inc.71$69,645
Alkermes, Inc.43$36,366
Otsuka Pharmaceutical Development & Commercialization, Inc.1$1,960
Eli Lilly and Company3$1,900
Neurocrine BioSciences, Inc.5$134
Vanda Pharmaceuticals Inc.6$113
Lundbeck LLC2$50

Products named: COBENFY, CAPLYTA, REXULTI, Auvelity, ARISTADA, LYBALVI, REJOYN, INGREZZA.

Industry payments across PA — which companies pay providers there.